186 related articles for article (PubMed ID: 15804420)
1. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning.
Yu X; Chen S; Potter OL; Murthy SM; Li J; Pulcini JM; Ohashi N; Winata T; Everett ET; Ingram D; Clapp WD; Hock JM
Bone; 2005 May; 36(5):793-802. PubMed ID: 15804420
[TBL] [Abstract][Full Text] [Related]
2. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.
Kuorilehto T; Nissinen M; Koivunen J; Benson MD; Peltonen J
J Bone Miner Res; 2004 Jun; 19(6):983-9. PubMed ID: 15125795
[TBL] [Abstract][Full Text] [Related]
3. Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model.
Li H; Liu Y; Zhang Q; Jing Y; Chen S; Song Z; Yan J; Li Y; Wu X; Zhang X; Zhang Y; Case J; Yu M; Ingram DA; Yang FC
Pediatr Res; 2009 Jun; 65(6):613-8. PubMed ID: 19247213
[TBL] [Abstract][Full Text] [Related]
4. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
[TBL] [Abstract][Full Text] [Related]
5. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
6. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
7. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
[TBL] [Abstract][Full Text] [Related]
8. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
9. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells.
Wu X; Estwick SA; Chen S; Yu M; Ming W; Nebesio TD; Li Y; Yuan J; Kapur R; Ingram D; Yoder MC; Yang FC
Hum Mol Genet; 2006 Oct; 15(19):2837-45. PubMed ID: 16893911
[TBL] [Abstract][Full Text] [Related]
11. Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation.
Gutmann DH; Cole JL; Collins FS
J Neurosci Res; 1994 Feb; 37(3):398-405. PubMed ID: 8176761
[TBL] [Abstract][Full Text] [Related]
12. Multiple roles for neurofibromin in skeletal development and growth.
Kolanczyk M; Kossler N; Kühnisch J; Lavitas L; Stricker S; Wilkening U; Manjubala I; Fratzl P; Spörle R; Herrmann BG; Parada LF; Kornak U; Mundlos S
Hum Mol Genet; 2007 Apr; 16(8):874-86. PubMed ID: 17317783
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
14. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation.
Gutmann DH; Tennekoon GI; Cole JL; Collins FS; Rutkowski JL
J Neurosci Res; 1993 Oct; 36(2):216-23. PubMed ID: 7505343
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity.
Tong J; Hannan F; Zhu Y; Bernards A; Zhong Y
Nat Neurosci; 2002 Feb; 5(2):95-6. PubMed ID: 11788835
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
[TBL] [Abstract][Full Text] [Related]
18. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
19. Recql4 haploinsufficiency in mice leads to defects in osteoblast progenitors: Implications for low bone mass phenotype.
Yang J; Murthy S; Winata T; Werner S; Abe M; Prahalad AK; Hock JM
Biochem Biophys Res Commun; 2006 May; 344(1):346-52. PubMed ID: 16600186
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromin signaling and synapses.
Hsueh YP
J Biomed Sci; 2007 Jul; 14(4):461-6. PubMed ID: 17370141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
